Sign in
  • R&D
  • Clinical
  • Commercial
    • Brand & Marketing
  • Technology
  • Insights
  • Podcast
  • Awards
    • LSV Top Industry Leaders Award 2025 Winners
    • Rising Stars Award 2026 Nomination
  • More
    • Manufacturing
    • Regulatory
    • Editorial
Sign in
Welcome!Log into your account
Forgot your password?
Privacy Policy
Password recovery
Recover your password
Search
LogoLifeNewsLife Science
LogoFashion Trends and Culture
  • R&D
    • Research & Development

      Early research shows that Lilly’s Verve strategy is successful in lowering cholesterol

      June 2, 2026
      Research & Development

      Kailera Details Nasdaq IPO Plans to Raise Up to $528.5 Million for Obesity Drug Development

      April 18, 2026
      Research & Development

      Avalyn Files for IPO to Fund Late-Stage Development of Inhaled Lung Disease Therapies

      April 10, 2026
      Research & Development

      Merck Pays $20 Million Upfront to Access Quotient’s Somatic Genomics Platform for IBD Research

      April 1, 2026
  • Clinical
    • Clinical

      cAMPfield Plans Mid-Stage Ulcerative Colitis and Crohn’s Disease Trials for Prifemilast

      June 23, 2026
      Clinical

      Definium’s LSD Formula Delivers Stunning Late-Stage Results

      June 23, 2026
      Clinical

      Merck Reports Positive Phase 3 Result for Tulisokibart in Ulcerative Colitis

      June 23, 2026
      Clinical

      Phase 3 Lagoon Trial Misses Survival Goal for Jazz’s Zepzelca in Second-Line Small Cell Lung Cancer

      June 19, 2026
  • Commercial
    • AllBrand & Marketing
      Commercial

      Eli Lilly Secures Global Rights to AlzeCure Alzheimer’s Drug Candidate in Deal Worth Over $1 Billion

      June 10, 2026
      Commercial

      Ascidian & Lilly Pen RNA Exon Editing Agreement for Genetic Kidney Issues

      June 9, 2026
      Commercial

      Travere Licenses Civorebrutinib From Everest Medicines in Deal Worth Up to $1.14 Billion

      June 9, 2026
  • Technology
    • Technology

      Alnylam Inks $2B Agreement With Inceptive to Change sIRNA Design With AI Leader

      June 9, 2026
      Technology

      Chugai and Gero Partner to Develop Antibodies for Age-Related Diseases Using AI

      July 7, 2025
      Technology

      J&J MedTech presents the first Ottava surgical robot clinical cases

      April 17, 2025
      Commercial

      Wisp Launches Weight Care Vertical for Women with Hormonal Imbalances

      October 23, 2024
  • Insights
    • Insights

      Top 10 AI Applications Transforming Pharmaceutical Market Access

      June 23, 2026
      Insights

      The Future of Scientific Engagement in an AI-Driven World

      June 23, 2026
      Insights

      Top 10 Data Architecture Challenges in Modern Pharma Organizations

      June 19, 2026
      Insights

      The Next Evolution of Decentralized Clinical Trials

      June 19, 2026
  • Podcast
  • Awards
    • LSV Top Industry Leaders Award 2025 Winners
    • Rising Stars Award 2026 Nomination
  • More
    • Manufacturing
    • Regulatory
    • Editorial
type here...
Facebook
Linkedin
X
Home Tags Aligos

Tag: Aligos

Aligos
Clinical

Aligos Therapeutics Secures $25 Million by Granting China Rights for HBV Drug Candidate

Editorial Team -
April 23, 2026
0

Editor Picks

Research raises concerns over Covid-19 drug Paxlovid

February 26, 2023

Developments in RNA Research Win Nobel Prizes for the Second Consecutive Year

October 11, 2024

Novo’s Wegovy Successful in Reducing Risk of Cardiovascular Events in Phase 3 Trial

August 8, 2023

Must Read

Top 10 AI Applications Transforming Pharmaceutical Market Access

June 23, 2026

The Future of Scientific Engagement in an AI-Driven World

June 23, 2026

cAMPfield Plans Mid-Stage Ulcerative Colitis and Crohn’s Disease Trials for Prifemilast

June 23, 2026

Hot Topics

  • Clinical462
  • Commercial409
  • Regulatory333
  • Insights116
  • Research & Development106
  • Manufacturing90
  • Newsletter59
  • Technology41
Logo

About Us

Life Sciences Voice is the leading resource for life sciences executives to get crucial insights, explore the latest innovations, and learn about industry trends. Life Sciences Voice provides the community with thought-provoking commentary in multiple formats covering a range of issues from drug discovery to commercial success.

Contact us: reachout(at)lifescivoice.com

Follow Us

Facebook
Instagram
Linkedin
X

© Copyright - Life Sciences Voice

  • R&D
  • Clinical
  • Commercial
  • Technology
  • Insights
  • Podcast
  • Awards
    • LSV Top Industry Leaders Award 2025 Winners
    • Rising Stars Award 2026 Nomination
  • More
    • Manufacturing
    • Regulatory
    • Editorial